ASCEND BY NTHRYS
Research Abroad Products

Biostatistics Project Topics

Browse all focused areas across all project categories under this field.

Showing 85–96 of 200 project topics
Regulatory-Grade Meta-Analysis Reporting and GCP Compliance Automation
An enterprise platform that automates generation of FDA/EMA-compliant meta-analysis reports with audit trails, CONSORT checklist completion, and integrated regulatory submission templates. This tool helps biostatistics service providers deliver regulatory-ready evidence packages in weeks rather than months, supporting higher-value contract wins and regulatory consulting retainers.
Meta-Analysis & Systematic Review Tools Click to view more details →
Network Meta-Analysis Graph Database and Treatment Comparison Platform
A commercial platform that stores and visualizes network meta-analysis data structures using graph databases, enabling dynamic comparison of treatment hierarchies, indirect treatment inferences, and real-time evidence network updates. Biostatistics firms and health economics companies monetize this through subscription licensing, managed services for network maintenance, and decision-support consulting for payers and manufacturers.
Meta-Analysis & Systematic Review Tools Click to view more details →
Rapid Living Systematic Review Management System with Version Control
A specialized platform designed for continuous, rolling meta-analyses that automatically ingests new published studies, reruns analyses, flags meaningful evidence updates, and distributes revision alerts to stakeholders. This subscription-based tool serves pharmaceutical monitoring, health outcomes research firms, and evidence synthesis organizations that charge clients monthly fees for continuously updated evidence briefings.
Meta-Analysis & Systematic Review Tools Click to view more details →
Machine Learning-Powered Risk of Bias Assessment Automation Tool
A software service that uses computer vision and natural language processing to automatically score risk of bias across multiple assessment tools (RoB 2, JADAD, Newcastle-Ottawa) from PDF study documents. This automation reduces the most time-intensive meta-analysis task by 85%, enabling biostatistics vendors to scale their service capacity without proportional headcount increases, improving gross margins by 40-50%.
Meta-Analysis & Systematic Review Tools Click to view more details →
Evidence Synthesis Cloud Collaboration Platform with Institutional Licensing
An SaaS platform providing real-time collaborative meta-analysis workspaces with role-based permissions, version control, audit logging, and institutional single sign-on for distributed systematic review teams across academic medical centers and health systems. This platform is monetized through institutional licensing tiers and professional services for evidence synthesis projects, targeting the growing academic and hospital systemmarket.
Meta-Analysis & Systematic Review Tools Click to view more details →
Predictive Meta-Regression and Subgroup Analysis Recommendation Engine
An AI-driven platform that recommends optimal meta-regression models, subgroup specifications, and interaction terms based on study-level covariates, using automated variable selection and cross-validation to prevent p-hacking in exploratory meta-analyses. Premium biostatistics consulting firms license this tool to deliver more credible subgroup evidence that supports regulatory approvals and market access decisions, justifying higher client fees.
Meta-Analysis & Systematic Review Tools Click to view more details →
Real-time Clinical Trial Data Management and Analysis Platform
A cloud-based SaaS platform that ingests, validates, and analyzes clinical trial data in real-time with automated quality checks and statistical monitoring. This reduces trial timelines by 30-40%, accelerates regulatory submissions, and enables sponsors to identify safety signals earlier, generating substantial cost savings and competitive advantages.
Biostatistics SaaS Platform for Pharma Industry Click to view more details →
Adaptive Trial Design and Interim Analysis Software Suite
An enterprise SaaS tool that automates adaptive trial designs, interim futility analyses, and sample size re-estimation with integrated simulation engines and regulatory reporting. Enables pharma sponsors to optimize trial budgets, reduce patient burden, and achieve faster time-to-market, increasing commercial ROI by enabling earlier pivots or go/no-go decisions.
Biostatistics SaaS Platform for Pharma Industry Click to view more details →
Bioequivalence and Pharmacokinetic Analysis Cloud Platform
A specialized SaaS platform for bioavailability/bioequivalence (BE) and pharmacokinetic (PK) analysis with built-in IVIVC modeling, population PK capabilities, and regulatory-compliant reporting templates. Accelerates generic drug submissions and support studies, reducing analytical bottlenecks and enabling faster market entry for cost-competitive products.
Biostatistics SaaS Platform for Pharma Industry Click to view more details →
Pharmacovigilance and Post-Market Safety Signal Detection Engine
An AI-powered SaaS platform that aggregates adverse event reports from multiple sources, applies machine learning algorithms for signal detection, and generates regulatory-grade safety reports. Enables pharmaceutical companies to reduce signal detection time, minimize liability exposure, and maintain compliance with FDA and EMA requirements, protecting brand reputation and revenue.
Biostatistics SaaS Platform for Pharma Industry Click to view more details →
Real-World Evidence and Observational Study Analytics Platform
A comprehensive SaaS solution that integrates real-world data from EHRs, claims databases, and registries to conduct observational studies and post-market effectiveness research. Drives commercial value through evidence-based marketing, health economics submissions, and payer negotiations, generating premium pricing and expanded market access.
Biostatistics SaaS Platform for Pharma Industry Click to view more details →
Regulatory Submission and Statistical Report Automation Tool
A production-grade SaaS platform that automates creation of statistical sections, tables, figures, and listings (TFLs) for regulatory submissions (CTD, NDA, BLA) with audit trails and version control. Reduces submission preparation time by 50%, minimizes errors, and accelerates FDA/EMA approval cycles, enabling faster commercial launch and revenue generation.
Biostatistics SaaS Platform for Pharma Industry Click to view more details →